Effects of Prescription Omega-3 Acids on Glucose and Lipoprotein Lipids in Subjects With Hypertriglyceridemia
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to assess the effects of 4 g/d prescription omega-3 acid
ethyl esters (POM3), compared with a placebo, on indices of insulin sensitivity and
secretion, as well as aspects of the fasting and postprandial lipid and lipoprotein profiles,
in subjects with hypertriglyceridemia.